Novel Vascularized Human Liver Organoids for Modeling Alcohol-Induced Liver Injury and Developing Hepatoprotective Therapy. [PDF]
Yang K +13 more
europepmc +1 more source
SputOMICs identifies common and distinct markers in cystic fibrosis and chronic obstructive pulmonary disease. [PDF]
Frey DL +14 more
europepmc +1 more source
Significant Changes in Low-Abundance Protein Content Detected by Proteomic Analysis of Urine from Patients with Renal Stones After Extracorporeal Shock Wave Lithotripsy. [PDF]
Carestia E +11 more
europepmc +1 more source
Investigation of CCL18 and A1AT as potential urinary biomarkers for bladder cancer detection [PDF]
Abstract Background In this study, we further investigated the association of two biomarkers, CCL18 and A1AT, with bladder cancer (BCa) and evaluated the influence of potentially confounding factors in an experimental model.
Makito Miyake +2 more
exaly +5 more sources
Scavenger receptor class B, type I-mediated uptake of A1AT by pulmonary endothelial cells
In addition to exerting a potent anti-elastase function, α-1 antitrypsin (A1AT) maintains the structural integrity of the lung by inhibiting endothelial inflammation and apoptosis. A main serpin secreted in circulation by hepatocytes, A1AT requires uptake by the endothelium to achieve vasculoprotective effects.
Daniela N Petrusca +2 more
exaly +5 more sources
Diagnosis and Management of Patients With α1-Antitrypsin (A1AT) Deficiency [PDF]
Alpha(1)-antitrypsin (A1AT) deficiency is an autosomal codominant disease that can cause chronic liver disease, cirrhosis, and hepatocellular carcinoma in children and adults and increases risk for emphysema in adults. The development of symptomatic disease varies; some patients have life-threatening symptoms in childhood, whereas others remain ...
David R Nelson, Jeffrey H Teckman
exaly +3 more sources
Related searches:
Alpha1-antitrypsin (A1AT) accumulation in livers of emphysematous patients with A1AT deficiency
Human Pathology, 1972Abstract An inherited deficiency of alpha 1 -antitrypsin (A 1 AT) in human serum predisposes to the development of pulmonary emphysema. A 1 AT is synthesized primarily by the liver, but no specific liver abnormality has been described in deficient subjects with lung disease. Fourteen of 17 livers from emphysematous patients with a Pi z variant of A 1
Charles Mittman, Jack Lieberman
exaly +3 more sources
Purified A1AT holds promise as therapy for acute liver failure [PDF]
Katrina Ray
exaly +3 more sources
EFFECT OF INHALED CHROMIUM ON PULMONARY A1AT
Inhalation Toxicology, 2002A major health hazard to coal miners is development of emphysema following long-term exposure to coal dust. One mechanism underlying development of emphysema is the oxidation of critical methionine (Met) residues in antiproteolytic factor, alpha1-antitrypsin (A1AT) resulting in a protease-antiprotease imbalance in the lung.
Mitchell D Cohen +2 more
exaly +3 more sources
A1AT In Human Neutrophil Granulocytes.
Blood, 2010Abstract Abstract 3784 Alpha-1-antitrypsin (A1AT) is an important inhibitor of the neutrophil serine proteases elastase, cathepsin G, and proteinase 3. A1AT is produced mainly by the liver and secreted to plasma. A1AT deficiency caused by the PiZZ mutation in the A1AT gene leads to accumulation of mutated A1AT in the liver
Stine Novrup Clemmensen +8 more
openaire +1 more source

